nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP2B6—Thiotepa—sarcoma	0.164	0.198	CbGbCtD
Midazolam—CYP2E1—Dacarbazine—sarcoma	0.0922	0.111	CbGbCtD
Midazolam—CYP2E1—Mitoxantrone—sarcoma	0.0715	0.0864	CbGbCtD
Midazolam—CYP3A7—Vincristine—sarcoma	0.051	0.0616	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.051	0.0616	CbGbCtD
Midazolam—CYP3A4—Thiotepa—sarcoma	0.0504	0.0609	CbGbCtD
Midazolam—CYP2E1—Etoposide—sarcoma	0.0451	0.0545	CbGbCtD
Midazolam—ABCB1—Dactinomycin—sarcoma	0.0404	0.0488	CbGbCtD
Midazolam—CYP3A5—Vincristine—sarcoma	0.0382	0.0462	CbGbCtD
Midazolam—ABCB1—Mitoxantrone—sarcoma	0.0362	0.0437	CbGbCtD
Midazolam—CYP3A5—Etoposide—sarcoma	0.035	0.0423	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—sarcoma	0.0303	0.0366	CbGbCtD
Midazolam—ABCB1—Vincristine—sarcoma	0.0249	0.0301	CbGbCtD
Midazolam—ABCB1—Etoposide—sarcoma	0.0228	0.0275	CbGbCtD
Midazolam—CYP3A4—Mitoxantrone—sarcoma	0.0217	0.0262	CbGbCtD
Midazolam—ABCB1—Doxorubicin—sarcoma	0.0156	0.0188	CbGbCtD
Midazolam—CYP3A4—Vincristine—sarcoma	0.0149	0.018	CbGbCtD
Midazolam—CYP3A4—Etoposide—sarcoma	0.0137	0.0165	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—sarcoma	0.00932	0.0113	CbGbCtD
Midazolam—UGT1A4—hematopoietic system—sarcoma	0.000701	0.0579	CbGeAlD
Midazolam—GABRP—mammary gland—sarcoma	0.000639	0.0528	CbGeAlD
Midazolam—Dysarthria—Epirubicin—sarcoma	0.000624	0.00391	CcSEcCtD
Midazolam—Nervousness—Thiotepa—sarcoma	0.000622	0.0039	CcSEcCtD
Midazolam—Cardiac disorder—Vincristine—sarcoma	0.000606	0.0038	CcSEcCtD
Midazolam—Ventricular extrasystoles—Doxorubicin—sarcoma	0.000605	0.00379	CcSEcCtD
Midazolam—Vision blurred—Thiotepa—sarcoma	0.000604	0.00378	CcSEcCtD
Midazolam—Ventricular tachycardia—Epirubicin—sarcoma	0.00059	0.0037	CcSEcCtD
Midazolam—Hiccups—Epirubicin—sarcoma	0.00059	0.0037	CcSEcCtD
Midazolam—Agitation—Thiotepa—sarcoma	0.000589	0.00369	CcSEcCtD
Midazolam—Mediastinal disorder—Vincristine—sarcoma	0.000588	0.00369	CcSEcCtD
Midazolam—Dyskinesia—Doxorubicin—sarcoma	0.000581	0.00364	CcSEcCtD
Midazolam—Dysarthria—Doxorubicin—sarcoma	0.000577	0.00362	CcSEcCtD
Midazolam—Neuropathy peripheral—Etoposide—sarcoma	0.000577	0.00362	CcSEcCtD
Midazolam—Salivary hypersecretion—Epirubicin—sarcoma	0.000573	0.00359	CcSEcCtD
Midazolam—Mental disorder—Vincristine—sarcoma	0.000572	0.00358	CcSEcCtD
Midazolam—Chills—Mitoxantrone—sarcoma	0.00057	0.00357	CcSEcCtD
Midazolam—Skin exfoliation—Epirubicin—sarcoma	0.000563	0.00353	CcSEcCtD
Midazolam—Cough—Thiotepa—sarcoma	0.000559	0.0035	CcSEcCtD
Midazolam—Erythema—Mitoxantrone—sarcoma	0.000553	0.00347	CcSEcCtD
Midazolam—Hiccups—Doxorubicin—sarcoma	0.000546	0.00342	CcSEcCtD
Midazolam—Ventricular tachycardia—Doxorubicin—sarcoma	0.000546	0.00342	CcSEcCtD
Midazolam—Anxiety—Thiotepa—sarcoma	0.000544	0.00341	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000542	0.00339	CcSEcCtD
Midazolam—Salivary hypersecretion—Doxorubicin—sarcoma	0.00053	0.00332	CcSEcCtD
Midazolam—Confusional state—Thiotepa—sarcoma	0.000527	0.0033	CcSEcCtD
Midazolam—CYP4B1—cardiac atrium—sarcoma	0.000525	0.0434	CbGeAlD
Midazolam—CYP4B1—uterus—sarcoma	0.000523	0.0431	CbGeAlD
Midazolam—Agitation—Vincristine—sarcoma	0.000522	0.00327	CcSEcCtD
Midazolam—Vision blurred—Mitoxantrone—sarcoma	0.000522	0.00327	CcSEcCtD
Midazolam—Skin exfoliation—Doxorubicin—sarcoma	0.000521	0.00327	CcSEcCtD
Midazolam—Nervous system disorder—Thiotepa—sarcoma	0.000513	0.00321	CcSEcCtD
Midazolam—Vertigo—Vincristine—sarcoma	0.000511	0.0032	CcSEcCtD
Midazolam—Tachycardia—Thiotepa—sarcoma	0.00051	0.0032	CcSEcCtD
Midazolam—Skin disorder—Thiotepa—sarcoma	0.000508	0.00318	CcSEcCtD
Midazolam—Phlebitis—Epirubicin—sarcoma	0.000497	0.00312	CcSEcCtD
Midazolam—Thrombophlebitis—Epirubicin—sarcoma	0.000495	0.0031	CcSEcCtD
Midazolam—Eye disorder—Etoposide—sarcoma	0.000494	0.0031	CcSEcCtD
Midazolam—Cardiac disorder—Etoposide—sarcoma	0.000491	0.00307	CcSEcCtD
Midazolam—GABRE—mammary gland—sarcoma	0.000488	0.0403	CbGeAlD
Midazolam—Cough—Mitoxantrone—sarcoma	0.000483	0.00303	CcSEcCtD
Midazolam—Immune system disorder—Etoposide—sarcoma	0.000478	0.00299	CcSEcCtD
Midazolam—Mediastinal disorder—Etoposide—sarcoma	0.000477	0.00299	CcSEcCtD
Midazolam—Chills—Etoposide—sarcoma	0.000474	0.00297	CcSEcCtD
Midazolam—Paraesthesia—Thiotepa—sarcoma	0.00047	0.00294	CcSEcCtD
Midazolam—Anxiety—Mitoxantrone—sarcoma	0.000469	0.00294	CcSEcCtD
Midazolam—Somnolence—Thiotepa—sarcoma	0.000465	0.00291	CcSEcCtD
Midazolam—Anaphylactic shock—Vincristine—sarcoma	0.000464	0.00291	CcSEcCtD
Midazolam—Dyspepsia—Thiotepa—sarcoma	0.00046	0.00288	CcSEcCtD
Midazolam—Phlebitis—Doxorubicin—sarcoma	0.00046	0.00288	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—sarcoma	0.000458	0.00287	CcSEcCtD
Midazolam—CYP4B1—tendon—sarcoma	0.000458	0.0378	CbGeAlD
Midazolam—Confusional state—Mitoxantrone—sarcoma	0.000455	0.00285	CcSEcCtD
Midazolam—Nervous system disorder—Vincristine—sarcoma	0.000455	0.00285	CcSEcCtD
Midazolam—Anaphylactic shock—Mitoxantrone—sarcoma	0.000452	0.00283	CcSEcCtD
Midazolam—Gastrointestinal disorder—Thiotepa—sarcoma	0.000451	0.00283	CcSEcCtD
Midazolam—Fatigue—Thiotepa—sarcoma	0.000451	0.00282	CcSEcCtD
Midazolam—Fatigue—Dactinomycin—sarcoma	0.000447	0.0028	CcSEcCtD
Midazolam—Pain—Thiotepa—sarcoma	0.000447	0.0028	CcSEcCtD
Midazolam—Constipation—Thiotepa—sarcoma	0.000447	0.0028	CcSEcCtD
Midazolam—Shock—Mitoxantrone—sarcoma	0.000444	0.00278	CcSEcCtD
Midazolam—Pain—Dactinomycin—sarcoma	0.000444	0.00278	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—sarcoma	0.000443	0.00277	CcSEcCtD
Midazolam—Tachycardia—Mitoxantrone—sarcoma	0.000441	0.00276	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—sarcoma	0.000439	0.00275	CcSEcCtD
Midazolam—Skin disorder—Mitoxantrone—sarcoma	0.000439	0.00275	CcSEcCtD
Midazolam—Lethargy—Epirubicin—sarcoma	0.000437	0.00274	CcSEcCtD
Midazolam—Hypotension—Vincristine—sarcoma	0.000433	0.00272	CcSEcCtD
Midazolam—Feeling abnormal—Thiotepa—sarcoma	0.000431	0.0027	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—sarcoma	0.000428	0.00268	CcSEcCtD
Midazolam—Diplopia—Epirubicin—sarcoma	0.000428	0.00268	CcSEcCtD
Midazolam—Feeling abnormal—Dactinomycin—sarcoma	0.000428	0.00268	CcSEcCtD
Midazolam—Hypotension—Mitoxantrone—sarcoma	0.000422	0.00264	CcSEcCtD
Midazolam—Affect lability—Epirubicin—sarcoma	0.000422	0.00264	CcSEcCtD
Midazolam—Paraesthesia—Vincristine—sarcoma	0.000416	0.00261	CcSEcCtD
Midazolam—Urticaria—Thiotepa—sarcoma	0.000415	0.0026	CcSEcCtD
Midazolam—Vertigo—Etoposide—sarcoma	0.000414	0.00259	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00041	0.00257	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—sarcoma	0.000407	0.00255	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—sarcoma	0.000406	0.00255	CcSEcCtD
Midazolam—Mood swings—Epirubicin—sarcoma	0.000406	0.00254	CcSEcCtD
Midazolam—Paraesthesia—Mitoxantrone—sarcoma	0.000406	0.00254	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—sarcoma	0.000405	0.00253	CcSEcCtD
Midazolam—Ataxia—Epirubicin—sarcoma	0.000403	0.00252	CcSEcCtD
Midazolam—Dyspnoea—Mitoxantrone—sarcoma	0.000403	0.00252	CcSEcCtD
Midazolam—Cough—Etoposide—sarcoma	0.000402	0.00252	CcSEcCtD
Midazolam—Somnolence—Mitoxantrone—sarcoma	0.000401	0.00252	CcSEcCtD
Midazolam—Gastrointestinal disorder—Vincristine—sarcoma	0.0004	0.00251	CcSEcCtD
Midazolam—Fatigue—Vincristine—sarcoma	0.0004	0.00251	CcSEcCtD
Midazolam—Dyspepsia—Mitoxantrone—sarcoma	0.000398	0.00249	CcSEcCtD
Midazolam—Pain—Vincristine—sarcoma	0.000397	0.00248	CcSEcCtD
Midazolam—Constipation—Vincristine—sarcoma	0.000397	0.00248	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—sarcoma	0.000396	0.00248	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—sarcoma	0.000396	0.00248	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—sarcoma	0.00039	0.00244	CcSEcCtD
Midazolam—Fatigue—Mitoxantrone—sarcoma	0.000389	0.00244	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000389	0.00244	CcSEcCtD
Midazolam—Pain—Mitoxantrone—sarcoma	0.000386	0.00242	CcSEcCtD
Midazolam—Constipation—Mitoxantrone—sarcoma	0.000386	0.00242	CcSEcCtD
Midazolam—Hypersensitivity—Thiotepa—sarcoma	0.000385	0.00241	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—sarcoma	0.000383	0.0024	CcSEcCtD
Midazolam—Hypersensitivity—Dactinomycin—sarcoma	0.000382	0.0024	CcSEcCtD
Midazolam—CYP4B1—testis—sarcoma	0.000379	0.0313	CbGeAlD
Midazolam—Confusional state—Etoposide—sarcoma	0.000379	0.00237	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—sarcoma	0.000378	0.00237	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—sarcoma	0.000377	0.00236	CcSEcCtD
Midazolam—Anaphylactic shock—Etoposide—sarcoma	0.000376	0.00235	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—sarcoma	0.000376	0.00235	CcSEcCtD
Midazolam—Asthenia—Thiotepa—sarcoma	0.000375	0.00235	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—sarcoma	0.000373	0.00234	CcSEcCtD
Midazolam—Asthenia—Dactinomycin—sarcoma	0.000372	0.00233	CcSEcCtD
Midazolam—Feeling abnormal—Mitoxantrone—sarcoma	0.000372	0.00233	CcSEcCtD
Midazolam—Pruritus—Thiotepa—sarcoma	0.00037	0.00232	CcSEcCtD
Midazolam—GABRR2—tendon—sarcoma	0.000369	0.0304	CbGeAlD
Midazolam—Tachycardia—Etoposide—sarcoma	0.000367	0.0023	CcSEcCtD
Midazolam—Skin disorder—Etoposide—sarcoma	0.000365	0.00229	CcSEcCtD
Midazolam—UGT1A4—liver—sarcoma	0.000363	0.03	CbGeAlD
Midazolam—Urticaria—Mitoxantrone—sarcoma	0.000359	0.00225	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—sarcoma	0.000354	0.00222	CcSEcCtD
Midazolam—Hypotension—Etoposide—sarcoma	0.000351	0.0022	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—sarcoma	0.00035	0.00219	CcSEcCtD
Midazolam—GABRE—myometrium—sarcoma	0.000346	0.0286	CbGeAlD
Midazolam—Dizziness—Thiotepa—sarcoma	0.000346	0.00217	CcSEcCtD
Midazolam—Hypersensitivity—Vincristine—sarcoma	0.000342	0.00214	CcSEcCtD
Midazolam—Paraesthesia—Etoposide—sarcoma	0.000337	0.00211	CcSEcCtD
Midazolam—Dyspnoea—Etoposide—sarcoma	0.000335	0.0021	CcSEcCtD
Midazolam—Somnolence—Etoposide—sarcoma	0.000334	0.00209	CcSEcCtD
Midazolam—Hypersensitivity—Mitoxantrone—sarcoma	0.000333	0.00208	CcSEcCtD
Midazolam—Asthenia—Vincristine—sarcoma	0.000333	0.00208	CcSEcCtD
Midazolam—Vomiting—Thiotepa—sarcoma	0.000333	0.00208	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—sarcoma	0.00033	0.00207	CcSEcCtD
Midazolam—Vomiting—Dactinomycin—sarcoma	0.00033	0.00207	CcSEcCtD
Midazolam—Rash—Thiotepa—sarcoma	0.00033	0.00207	CcSEcCtD
Midazolam—Dermatitis—Thiotepa—sarcoma	0.000329	0.00206	CcSEcCtD
Midazolam—Headache—Thiotepa—sarcoma	0.000328	0.00205	CcSEcCtD
Midazolam—Rash—Dactinomycin—sarcoma	0.000327	0.00205	CcSEcCtD
Midazolam—Gastrointestinal disorder—Etoposide—sarcoma	0.000324	0.00203	CcSEcCtD
Midazolam—Asthenia—Mitoxantrone—sarcoma	0.000324	0.00203	CcSEcCtD
Midazolam—Fatigue—Etoposide—sarcoma	0.000324	0.00203	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—sarcoma	0.000324	0.00203	CcSEcCtD
Midazolam—Pain—Etoposide—sarcoma	0.000321	0.00201	CcSEcCtD
Midazolam—Constipation—Etoposide—sarcoma	0.000321	0.00201	CcSEcCtD
Midazolam—GABRE—seminal vesicle—sarcoma	0.000313	0.0258	CbGeAlD
Midazolam—Nausea—Thiotepa—sarcoma	0.000311	0.00195	CcSEcCtD
Midazolam—Feeling abnormal—Etoposide—sarcoma	0.00031	0.00194	CcSEcCtD
Midazolam—Nausea—Dactinomycin—sarcoma	0.000308	0.00193	CcSEcCtD
Midazolam—GABRG3—testis—sarcoma	0.000308	0.0254	CbGeAlD
Midazolam—Dizziness—Vincristine—sarcoma	0.000307	0.00192	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—sarcoma	0.000305	0.00191	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—sarcoma	0.000302	0.00189	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—sarcoma	0.000299	0.00188	CcSEcCtD
Midazolam—Urticaria—Etoposide—sarcoma	0.000298	0.00187	CcSEcCtD
Midazolam—Vomiting—Vincristine—sarcoma	0.000295	0.00185	CcSEcCtD
Midazolam—GABRP—uterus—sarcoma	0.000294	0.0243	CbGeAlD
Midazolam—GABRR1—testis—sarcoma	0.000294	0.0242	CbGeAlD
Midazolam—Rash—Vincristine—sarcoma	0.000292	0.00183	CcSEcCtD
Midazolam—Dermatitis—Vincristine—sarcoma	0.000292	0.00183	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—sarcoma	0.000291	0.00182	CcSEcCtD
Midazolam—Headache—Vincristine—sarcoma	0.000291	0.00182	CcSEcCtD
Midazolam—Vomiting—Mitoxantrone—sarcoma	0.000287	0.0018	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—sarcoma	0.000286	0.00179	CcSEcCtD
Midazolam—Rash—Mitoxantrone—sarcoma	0.000285	0.00178	CcSEcCtD
Midazolam—Dermatitis—Mitoxantrone—sarcoma	0.000284	0.00178	CcSEcCtD
Midazolam—Headache—Mitoxantrone—sarcoma	0.000283	0.00177	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—sarcoma	0.000279	0.00175	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—sarcoma	0.000277	0.00174	CcSEcCtD
Midazolam—Hypersensitivity—Etoposide—sarcoma	0.000277	0.00173	CcSEcCtD
Midazolam—Nausea—Vincristine—sarcoma	0.000275	0.00173	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—sarcoma	0.000275	0.00172	CcSEcCtD
Midazolam—CYP4B1—lymph node—sarcoma	0.000275	0.0227	CbGeAlD
Midazolam—Asthenia—Etoposide—sarcoma	0.00027	0.00169	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—sarcoma	0.000269	0.00169	CcSEcCtD
Midazolam—Nausea—Mitoxantrone—sarcoma	0.000268	0.00168	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—sarcoma	0.000268	0.00168	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—sarcoma	0.000267	0.00167	CcSEcCtD
Midazolam—Chills—Epirubicin—sarcoma	0.000266	0.00167	CcSEcCtD
Midazolam—Pruritus—Etoposide—sarcoma	0.000266	0.00167	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—sarcoma	0.000264	0.00166	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—sarcoma	0.00026	0.00163	CcSEcCtD
Midazolam—GABRA4—tendon—sarcoma	0.00026	0.0214	CbGeAlD
Midazolam—Erythema—Epirubicin—sarcoma	0.000258	0.00162	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—sarcoma	0.000256	0.00161	CcSEcCtD
Midazolam—GABRD—testis—sarcoma	0.000255	0.0211	CbGeAlD
Midazolam—Cardiac disorder—Doxorubicin—sarcoma	0.000255	0.00159	CcSEcCtD
Midazolam—Tension—Epirubicin—sarcoma	0.000253	0.00159	CcSEcCtD
Midazolam—CYP3A7—liver—sarcoma	0.000253	0.0209	CbGeAlD
Midazolam—Nervousness—Epirubicin—sarcoma	0.000251	0.00157	CcSEcCtD
Midazolam—Dizziness—Etoposide—sarcoma	0.000248	0.00156	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—sarcoma	0.000248	0.00155	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—sarcoma	0.000247	0.00155	CcSEcCtD
Midazolam—Chills—Doxorubicin—sarcoma	0.000246	0.00154	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—sarcoma	0.000243	0.00152	CcSEcCtD
Midazolam—GABRB3—connective tissue—sarcoma	0.000243	0.02	CbGeAlD
Midazolam—Mental disorder—Doxorubicin—sarcoma	0.00024	0.00151	CcSEcCtD
Midazolam—Vomiting—Etoposide—sarcoma	0.000239	0.0015	CcSEcCtD
Midazolam—Erythema—Doxorubicin—sarcoma	0.000239	0.0015	CcSEcCtD
Midazolam—Agitation—Epirubicin—sarcoma	0.000237	0.00149	CcSEcCtD
Midazolam—GABRA5—testis—sarcoma	0.000237	0.0196	CbGeAlD
Midazolam—Rash—Etoposide—sarcoma	0.000237	0.00148	CcSEcCtD
Midazolam—Dermatitis—Etoposide—sarcoma	0.000237	0.00148	CcSEcCtD
Midazolam—Headache—Etoposide—sarcoma	0.000235	0.00147	CcSEcCtD
Midazolam—Tension—Doxorubicin—sarcoma	0.000234	0.00147	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—sarcoma	0.000232	0.00145	CcSEcCtD
Midazolam—Vertigo—Epirubicin—sarcoma	0.000232	0.00145	CcSEcCtD
Midazolam—Syncope—Epirubicin—sarcoma	0.000231	0.00145	CcSEcCtD
Midazolam—GABRE—cardiac atrium—sarcoma	0.000226	0.0186	CbGeAlD
Midazolam—Cough—Epirubicin—sarcoma	0.000225	0.00141	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—sarcoma	0.000225	0.00141	CcSEcCtD
Midazolam—Nausea—Etoposide—sarcoma	0.000223	0.0014	CcSEcCtD
Midazolam—GABRR2—lymph node—sarcoma	0.000221	0.0183	CbGeAlD
Midazolam—GABRA3—testis—sarcoma	0.000221	0.0182	CbGeAlD
Midazolam—Agitation—Doxorubicin—sarcoma	0.000219	0.00137	CcSEcCtD
Midazolam—Anxiety—Epirubicin—sarcoma	0.000219	0.00137	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000218	0.00137	CcSEcCtD
Midazolam—CYP3A7-CYP3A51P—liver—sarcoma	0.000215	0.0178	CbGeAlD
Midazolam—Dry mouth—Epirubicin—sarcoma	0.000215	0.00135	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—sarcoma	0.000214	0.00134	CcSEcCtD
Midazolam—Syncope—Doxorubicin—sarcoma	0.000214	0.00134	CcSEcCtD
Midazolam—Confusional state—Epirubicin—sarcoma	0.000212	0.00133	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—sarcoma	0.000211	0.00132	CcSEcCtD
Midazolam—Cough—Doxorubicin—sarcoma	0.000208	0.00131	CcSEcCtD
Midazolam—Shock—Epirubicin—sarcoma	0.000207	0.0013	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—sarcoma	0.000207	0.00129	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—sarcoma	0.000206	0.00129	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—sarcoma	0.000205	0.00128	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—sarcoma	0.000203	0.00127	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000202	0.00126	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—sarcoma	0.000199	0.00125	CcSEcCtD
Midazolam—GABRE—tendon—sarcoma	0.000197	0.0162	CbGeAlD
Midazolam—Hypotension—Epirubicin—sarcoma	0.000197	0.00123	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—sarcoma	0.000196	0.00123	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—sarcoma	0.000195	0.00122	CcSEcCtD
Midazolam—Shock—Doxorubicin—sarcoma	0.000192	0.0012	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—sarcoma	0.000191	0.0012	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—sarcoma	0.00019	0.00119	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—sarcoma	0.000189	0.00119	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—sarcoma	0.000189	0.00118	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—sarcoma	0.000188	0.00118	CcSEcCtD
Midazolam—Somnolence—Epirubicin—sarcoma	0.000187	0.00117	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—sarcoma	0.000185	0.00116	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—sarcoma	0.000182	0.00114	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—sarcoma	0.000182	0.00114	CcSEcCtD
Midazolam—Fatigue—Epirubicin—sarcoma	0.000182	0.00114	CcSEcCtD
Midazolam—Pain—Epirubicin—sarcoma	0.00018	0.00113	CcSEcCtD
Midazolam—Constipation—Epirubicin—sarcoma	0.00018	0.00113	CcSEcCtD
Midazolam—GABRB2—testis—sarcoma	0.00018	0.0148	CbGeAlD
Midazolam—Paraesthesia—Doxorubicin—sarcoma	0.000175	0.0011	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—sarcoma	0.000174	0.00109	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—sarcoma	0.000174	0.00109	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—sarcoma	0.000173	0.00109	CcSEcCtD
Midazolam—CYP3A5—hematopoietic system—sarcoma	0.000172	0.0142	CbGeAlD
Midazolam—Dyspepsia—Doxorubicin—sarcoma	0.000172	0.00107	CcSEcCtD
Midazolam—CYP2B6—hematopoietic system—sarcoma	0.000171	0.0141	CbGeAlD
Midazolam—CYP2E1—seminal vesicle—sarcoma	0.000169	0.0139	CbGeAlD
Midazolam—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000168	0.00105	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—sarcoma	0.000168	0.00105	CcSEcCtD
Midazolam—Urticaria—Epirubicin—sarcoma	0.000167	0.00105	CcSEcCtD
Midazolam—Pain—Doxorubicin—sarcoma	0.000167	0.00104	CcSEcCtD
Midazolam—Constipation—Doxorubicin—sarcoma	0.000167	0.00104	CcSEcCtD
Midazolam—GABRE—testis—sarcoma	0.000163	0.0134	CbGeAlD
Midazolam—Feeling abnormal—Doxorubicin—sarcoma	0.000161	0.00101	CcSEcCtD
Midazolam—CYP2E1—hematopoietic system—sarcoma	0.00016	0.0132	CbGeAlD
Midazolam—Hypersensitivity—Epirubicin—sarcoma	0.000155	0.000972	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—sarcoma	0.000155	0.00097	CcSEcCtD
Midazolam—Asthenia—Epirubicin—sarcoma	0.000151	0.000947	CcSEcCtD
Midazolam—Pruritus—Epirubicin—sarcoma	0.000149	0.000933	CcSEcCtD
Midazolam—CYP2B6—skin of body—sarcoma	0.000149	0.0123	CbGeAlD
Midazolam—SLC22A1—liver—sarcoma	0.000147	0.0121	CbGeAlD
Midazolam—Hypersensitivity—Doxorubicin—sarcoma	0.000144	0.000899	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—sarcoma	0.00014	0.000876	CcSEcCtD
Midazolam—Dizziness—Epirubicin—sarcoma	0.000139	0.000872	CcSEcCtD
Midazolam—GABRB3—testis—sarcoma	0.000138	0.0114	CbGeAlD
Midazolam—Pruritus—Doxorubicin—sarcoma	0.000138	0.000864	CcSEcCtD
Midazolam—Vomiting—Epirubicin—sarcoma	0.000134	0.000839	CcSEcCtD
Midazolam—Rash—Epirubicin—sarcoma	0.000133	0.000832	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—sarcoma	0.000133	0.000831	CcSEcCtD
Midazolam—Headache—Epirubicin—sarcoma	0.000132	0.000827	CcSEcCtD
Midazolam—GABRB3—liver—sarcoma	0.000131	0.0108	CbGeAlD
Midazolam—CYP3A4—hematopoietic system—sarcoma	0.000129	0.0106	CbGeAlD
Midazolam—Dizziness—Doxorubicin—sarcoma	0.000129	0.000807	CcSEcCtD
Midazolam—Nausea—Epirubicin—sarcoma	0.000125	0.000784	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—sarcoma	0.000124	0.000776	CcSEcCtD
Midazolam—Rash—Doxorubicin—sarcoma	0.000123	0.00077	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—sarcoma	0.000123	0.000769	CcSEcCtD
Midazolam—Headache—Doxorubicin—sarcoma	0.000122	0.000765	CcSEcCtD
Midazolam—CYP2B6—lymphoid tissue—sarcoma	0.00012	0.00993	CbGeAlD
Midazolam—GABRA2—lymph node—sarcoma	0.000119	0.00983	CbGeAlD
Midazolam—GABRE—lymph node—sarcoma	0.000118	0.00975	CbGeAlD
Midazolam—Nausea—Doxorubicin—sarcoma	0.000116	0.000725	CcSEcCtD
Midazolam—CYP2E1—lymphoid tissue—sarcoma	0.000113	0.00932	CbGeAlD
Midazolam—ABCB1—myometrium—sarcoma	0.000106	0.00878	CbGeAlD
Midazolam—CYP2E1—tendon—sarcoma	0.000106	0.00876	CbGeAlD
Midazolam—ABCB1—embryo—sarcoma	0.000102	0.00844	CbGeAlD
Midazolam—ABCB1—seminal vesicle—sarcoma	9.61e-05	0.00793	CbGeAlD
Midazolam—CYP2B6—testis—sarcoma	9.36e-05	0.00773	CbGeAlD
Midazolam—ABCB1—hematopoietic system—sarcoma	9.13e-05	0.00754	CbGeAlD
Midazolam—CYP3A5—liver—sarcoma	8.91e-05	0.00735	CbGeAlD
Midazolam—CYP2B6—liver—sarcoma	8.85e-05	0.00731	CbGeAlD
Midazolam—CYP2E1—testis—sarcoma	8.79e-05	0.00725	CbGeAlD
Midazolam—CYP2E1—liver—sarcoma	8.31e-05	0.00686	CbGeAlD
Midazolam—ABCB1—uterus—sarcoma	6.9e-05	0.00569	CbGeAlD
Midazolam—CYP3A4—liver—sarcoma	6.68e-05	0.00552	CbGeAlD
Midazolam—ABCB1—lymphoid tissue—sarcoma	6.43e-05	0.00531	CbGeAlD
Midazolam—ABCB1—bone marrow—sarcoma	5.85e-05	0.00483	CbGeAlD
Midazolam—ABCB1—testis—sarcoma	5e-05	0.00413	CbGeAlD
Midazolam—ABCB1—liver—sarcoma	4.73e-05	0.00391	CbGeAlD
Midazolam—ABCB1—lymph node—sarcoma	3.63e-05	0.00299	CbGeAlD
